Skip to main content
Risikogruppen Odense

Søg

English
Menu

Publikationsliste

Forskningen indenfor risikogruppen har resulteret i en meget lang række publikation, som kan ses her. Listen er ikke komplet.

  1. Støvring H, Harmsen CG, Wisløff T, Jarbøl DE, Nexøe J, Nielsen JB and Kristiansen IS: A competing risk approach for the European Heart SCORE model based on cause-specific and all-cause mortality, European Journal of Preventive Cardiology published online 12 April 2012
  2. Nielsen JB, Elstein A, Gyrd-Hansen D, Kildemoes HW, Kristiansen IS, Stovring H. Effects of alternative styles of risk information on EMF risk perception. Bioelectromagnetics 2010.
  3. Halvorsen PA, Selmer RM, Kristiansen IS. Anticipated longevity among lay people screened for cardiovascular risk factors: a cross-sectional questionnaire study. Scand J Public Health 2010; 38(5):481-488.
  4. Kristiansen IS, Elstein AS, Gyrd-Hansen D, Kildemoes HW, Nielsen JB. Radiation from mobile phone systems: Is it perceived as a threat to people's health? Bioelectromagnetics 2009; 30(5):393-401.
  5. Stovring H, Gyrd-Hansen D, Kristiansen IS, Nexoe J, Nielsen JB. Communicating effectiveness of intervention for chronic diseases: what single format can replace comprehensive information? BMC Med Inform Decis Mak 2008; 8:25.
  6. Sorensen L, Gyrd-Hansen D, Kristiansen IS, Nexoe J, Nielsen JB. Laypersons' understanding of relative risk reductions: randomised cross-sectional study. BMC Med Inform Decis Mak 2008; 8:31
  7. Gyrd-Hansen D, Kristiansen IS. Preferences for 'life-saving' programmes: small for all or gambling for the prize? Health Econ 2008; 17(6):709-720.
  8. Halvorsen PA, Selmer R, Kristiansen IS. Different ways to describe the benefits of risk-reducing treatments: a randomized trial. Ann Intern Med 2007; 146(12):848-856.
  9. Kristiansen IS, Gyrd-Hansen D. Prioritering og helse - bør det indføres makspris på leveår? Tidsskr Nor Laegeforen 2007; 127(1):54-57.
  10. Nexoe J, Halvorsen PA, Kristiansen IS . Critiques of the risk concept—valid or not? Scand J Public Health 2007; 35(6):648-654.
  11. Kristiansen IS, Halvorsen PA, Gyrd-Hansen D. Influenza pandemic: Perception of risk and individual precautions in a general population. Cross-sectional study. BMC Public Health 2007; 7(1):48.
  12. Dahl R, Gyrd-Hansen D, Kristiansen IS, Nexoe J, Bo NJ. Can postponement of an adverse outcome be used to present risk reductions to a lay audience? A population survey. BMC Med Inform Decis Mak 2007; 7:8.
  13. Gyrd-Hansen D, Halvorsen PA, Kristiansen IS. Willingness-to-pay for a statistical life in the times of a pandemic. Health Econ 2007.
  14. Kristiansen IS, Gyrd-Hansen D, Nexoe J, Bo NJ. Willingness-to-pay for a population program aimed at reducing dietary salt in Denmark. Prev Med 2006.
  15. Kristiansen IS, Gyrd-Hansen D. Communicating treatment effectiveness in the context of chronic disease processes. Expert Rev Pharmacoeconomics Outcomes Res 2006; 6:673-679
  16. Kristiansen IS, Olsen JA. [Orphan drugs and sick patients]. Tidsskr Nor Laegeforen 2005; 125(8):992.
  17. Nexoe J, Kristiansen IS, Gyrd-Hansen D, Nielsen JB. Influence of number needed to treat, costs and outcome on preferences for a preventive drug. Fam Pract 2005; 22(1):126-131.
  18. Kildemoes HW, Nielsen JB, Kristiansen IS. Mobile phones in Denmark - use and risk perception (in Danish: Mobiltelefoni i Danmark - brug og risikoopfattelse). 2005. Odense, University of Southern Denmark. Ref Type: Report
  19. Halvorsen PA, Kristiansen IS. Decisions on drug therapies by numbers needed to treat: a randomized trial. Arch Intern Med 2005; 165(10):1140-1146.
  20. Christensen PM, Brixen K, Gyrd-Hansen D, Kristiansen IS. Cost-effectiveness of alendronate in the prevention of osteoporotic fractures in Danish women. Basic Clin Pharmacol Toxicol 2005; 96(5):387-396
  21. Fredriksen HB, Elverdam B, Hoelfelde LK, Nielsen JB. Mobile phones: a qualitative study of risk management in daily life (in Danish: Mobiltelefoner - en undersøgelse av risikohåndtering i hverdagslivet). 2005.
  22. Kildemoes HW, Kristiansen IS. Cost-effectiveness of interventions to reduce the thrombolytic delay for acute myocardial infarction. Int J Technol Assess Health Care 2004; 20(3):368-374.
  23. Kristiansen IS. Communicating effect of risk interventions in terms of postponement of adverse effect. Medical Decision Making 20, 422. 2004. Ref Type: Abstract
  24. Kristiansen IS, Gyrd-Hansen D. Cost-effectiveness analysis based on the number-needed-to-treat: common sense or non-sense? Health Econ 2004 Jan 1913;9-19.
  25. Nielsen JB, Gyrd-Hansen D, Kristiansen IS, Nexoe J. Impact of socio-demographic factors on willingness-to-pay for the reduction of a future health risk. J Environ Plan Manag 2004; 46:39-47.
  26. Kristiansen IS, Gyrd-Hansen D, Nexoe J, Nielsen JB. Goodbye NNT. J Clin Epidemiol 2004; 57(2):221.
  27. Wisloff T, Halvorsen PA, Kristiansen IS. [Number needed to treat: misleading, misunderstood, misused? ]. Tidsskr Nor Laegeforen 2004; 124(15):1926-1929.
  28. Halvorsen PA, Kristiansen IS, Aasland OG, Førde OH. Medical doctors' perception of the "number needed to treat" (NNT). Scand J Prim Health Care 2003; 21(3):162-6.
  29. Christensen PM, Brixen K, Brøsen K, Andersen M, Kristiansen IS. A randomised trial of laypersons' perception of the benefit of osteoporosis therapy: Number needed to treat versus postponement of hip fractures? Clin Ther 2003; 25:2275-85.
  30. Christensen PM, Brixen K, Kristiansen IS. Danish Osteoporosis Outcome Model (Technical report). Health Economics paper 2:2003. 2003. Odense, Health Economics Research Unit, University of Southern Denmark. Ref Type: Report
  31. Nielsen JB, Gyrd-Hansen D, Kristiansen IS, Nexoe J. Willingness to pay for decreased indoor radon exposure: an analysis of framing and the decision process. Risk Decis Policy 2003; 8:51-8.
  32. Wisloff TF, Kristiansen IS. [How to measure the effect of risk reduction?]. Tidsskr Nor Laegeforen 2003; 123(22):3266.
  33. Halvorsen PA, Kristiansen IS, Aasland OG, Forde OH. Medical doctors' perception of the "number needed to treat" (NNT). A survey of doctors' recommendations for two therapies with different NNT. Scand J Prim Health Care 2003; 21(3):162-166.
  34. Christensen PM, Brosen K, Brixen K, Andersen M, Kristiansen IS. A randomized trial of laypersons' perception of the benefit of osteoporosis therapy: Number needed to treat versus postponement of hip fracture. Clin Ther 2003; 25(10):2575-2585.
  35. Kristiansen IS, Stavem K, Linnestad K, Pedersen KM. [Evaluation of medical methods--can we rely on cost-benefit-analysis?]. Tidsskr Nor Laegeforen 2003; 123(5):657-660.
  36. Gyrd-Hansen D, Kristiansen IS, Nexoe J, Nielsen JB. How do individuals apply risk information when choosing among health care interventions? Risk Anal 2003; 23(4):697-704.
  37. Nexoe J, Gyrd-Hansen D, Kragstrup J, Kristiansen IS, Nielsen JB. Danish GPs' perception of disease risk and benefit of intervention. Family Practice 2002; 19:3-6.
  38. Kristiansen IS. Is 113 a large number? (in Norwegian). Diagnose Risiko. Oslo: Universitetsforlaget; 2002.
  39. Christensen PM, Brosen K, Brixen KT, Beck-Nielsen H, Sogaard J, Kristiansen IS. [Pharmaco-economic evaluation of drug therapy osteoporosis. A literature review]. Ugeskr Laeger 2002; 164(10):1339-1345.
  40. Nexoe J, Kristiansen IS. [Number needed to treat--a statistical case study]. Ugeskr Laeger 2002; 164(3):351.
  41. Kristiansen IS, Gyrd-Hansen D, Nexoe J, Nielsen JB. Number needed to treat: easily understood and intuitively meaningful? Theoretical considerations and a randomized trial. J Clin Epidemiol 2002; 55(9):888-902.
  42. Nexoe J, Oltarzewska AM, Sawicka-Powierza J, Kragstrup J, Kristiansen IS. Perception of risk information. Similarities and differences between Danish and Polish general practitioners. Scand J Prim Health Care 2002; 20(3):183-187.
  43. Madsen J, Serup-Hansen N, Kragstrup J, Kristiansen IS. Ageing may have limited impact on future costs of primary care providers. Scand J Prim Health Care 2002; 20(3):169-173.
  44. Kristiansen IS, Nexoe J, Gyrd-Hansen D, Nielsen JB. NNT is not easily understood. Fam Pract 2002; 19(5):566.
  45. Madsen J, Serup-Hansen N, Kristiansen IS. Future health care costs-do health care costs during the last year of life matter? Health Policy 2002; 62(2):161.
  46. Christensen PM, Brosen K, Brixen K, Kristiansen IS. Expressing effects of osteoporosis interventions in terms of postponing of fractures. Eur J Clin Pharmacol 2002; 58(9):629-633
  47. Kristiansen IS, Gyrd-Hansen D, Nexoe J, Nielsen JB. The concept of risk: a comment to Reventlow and co-workers. Scand J Prim Health Care 2002; 20(4):252.
  48. Christensen PM, Kristiansen IS, Brøsen K, Brixen K, Abrahamsen B, Andersen M. The use of prednisolone and concurrent pharmacological prophylaxis against osteoporosis - a population based study using a drug prescription database. Acta Orthop Scand (Suppl 287) 1999; 70:29
  49. Kristiansen IS, Thelle DS. [Use of risk number in chronic diseases. Number needed to cheat?]. Tidsskr Nor Laegeforen 1998;118(19):2938

Sidst opdateret: 30.06.2023